|
1
|
Du L and Ha C: Epidemiology and
pathogenesis of ulcerative colitis. Gastroenterol Clin North Am.
49:643–654. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ng SC, Shi HY, Hamidi N, Underwood FE,
Tang W, Benchimol EI, Panaccione R, Ghosh S, Wu JCY, Chan FKL, et
al: Worldwide incidence and prevalence of inflammatory bowel
disease in the 21st century: A systematic review of
population-based studies. Lancet. 390:2769–2778. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lopez A, Pouillon L, Beaugerie L, Danese S
and Peyrin-Biroulet L: Colorectal cancer prevention in patients
with ulcerative colitis. Best Prac Res Clin Gastroenterol.
32-33:103–109. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liang Y, Li Y, Lee C, Yu Z, Chen C and
Liang C: Ulcerative colitis: Molecular insights and intervention
therapy. Mol Biomed. 5:422024. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Asgharzadeh F, Yaghoubi A, Nazari SE,
Hashemzadeh A, Hasanian SM, Avan A, Javandoost A, Ferns GA,
Soleimanpour S and Khazaei M: The beneficial effect of combination
therapy with sulfasalazine and valsartan in the treatment of
ulcerative colitis. EXCLI J. 20:236–247. 2021.PubMed/NCBI
|
|
6
|
Chelakkot C, Ghim J and Ryu SH: Mechanisms
regulating intestinal barrier integrity and its pathological
implications. Exp Mol Med. 50:1–9. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bertheloot D, Latz E and Franklin BS:
Necroptosis, pyroptosis and apoptosis: An intricate game of cell
death. Cell Mol Immunol. 18:1106–1121. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
D'Arcy MS: Cell death: A review of the
major forms of apoptosis, necrosis and autophagy. Cell Biol Int.
43:582–592. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Khy MK, Gupta K, Franco SR and Liu B:
Necroptosis in the pathophysiology of disease. Am J Pathol.
190:272–285. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Negroni A, Colantoni E, Cucchiara S and
Stronati L: Necroptosis in intestinal inflammation and cancer: New
concepts and therapeutic perspectives. Biomolecules. 10:14312020.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gaba A, Xu F, Lu Y, Park H-S, Liu G and
Zhou Y: The NS1 protein of influenza a virus participates in
necroptosis by interacting with MLKL and increasing its
oligomerization and membrane translocation. J Virol. 93:e01835–18.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zeb S, Ye H, Liu Y, Du HP, Guo Y, Zhu YM,
Ni Y, Zhang HL and Xu Y: Necroptotic kinases are involved in the
reduction of depression-induced astrocytes and fluoxetine's
inhibitory effects on necroptotic kinases. Front Pharmacol.
13:10609542023. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li Z, Wang H, Wang Z and Geng Y: Pine
pollen polysaccharides' and sulfated polysaccharides' effects on UC
mice through modulation of cell tight junctions and RIPK3-dependent
necroptosis pathways. Molecules. 27:76822022. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lee SH, Kwon JY, Moon J, Choi J, Jhun J,
Jung K, Cho KH, Darlami O, Lee HH, Jung ES, et al: Inhibition of
RIPK3 pathway attenuates intestinal inflammation and cell death of
inflammatory bowel disease and suppresses necroptosis in peripheral
mononuclear cells of ulcerative colitis patients. Immune Network.
20:e162020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu Y, Li BG, Su YH, Zhao RX, Song P, Li
H, Cui XH, Gao HM, Zhai RX, Fu XJ and Ren X: Potential activity of
traditional Chinese medicine against ulcerative colitis: A review.
J Ethnopharmacol. 289:1150842022. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang M, Fu R, Xu D, Chen Y, Yue S, Zhang S
and Tang Y: Traditional Chinese medicine: A promising strategy to
regulate the imbalance of bacterial flora, impaired intestinal
barrier and immune function attributed to ulcerative colitis
through intestinal microecology. J Ethnopharmacol. 318:1168792024.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhao Q, Bi Y, Zhong J, Ren Z, Liu Y, Jia
J, Yu M, Tan Y, Zhang Q and Yu X: Pristimerin suppresses colorectal
cancer through inhibiting inflammatory responses and Wnt/β-catenin
signaling. Toxicol Appl Pharmacol. 386:1148132020. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cai Z, Zhang A, Choksi S, Li W, Li T,
Zhang XM and Liu ZG: Activation of cell-surface proteases promotes
necroptosis, inflammation and cell migration. Cell Res. 26:886–900.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhu K, Liang W, Ma Z, Xu D, Cao S, Lu X,
Liu N, Shan B, Qian L and Yuan J: Necroptosis promotes
cell-autonomous activation of proinflammatory cytokine gene
expression. Cell Death Dis. 9:5002018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shen X, Chen H, Wen T, Liu L, Yang Y, Xie
F and Wang L: A natural chalcone cardamonin inhibits necroptosis
and ameliorates dextran sulfate sodium (DSS)-induced colitis by
targeting RIPK1/3 kinases. Eur J Pharmacol. 954:1758402023.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang LN, Wang Y, Lu Y, Yin ZF, Zhang YH,
Aslanidi GV, Srivastava A, Ling CQ and Ling C: Pristimerin enhances
recombinant adeno-associated virus vector-mediated transgene
expression in human cell lines in vitro and murine hepatocytes in
vivo. J Integr Med. 12:20–34. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liang J, Yuan S, Wang X, Lei Y, Zhang X,
Huang M and Ouyang H: Attenuation of pristimerin on TNF-α-induced
endothelial inflammation. Int Immunopharmacol. 82:1063262020.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang D, Ge F, Ji J, Li YJ, Zhang FR, Wang
SY, Zhang SJ, Zhang DM and Chen M: β-sitosterol alleviates dextran
sulfate sodium-induced experimental colitis via inhibition of
NLRP3/Caspase-1/GSDMD-mediated pyroptosis. Front Pharmacol.
14:12184772023. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yan YX, Shao MJ, Qi Q, Xu YS, Yang XQ, Zhu
FH, He SJ, He PL, Feng CL, Wu YW, et al: Artemisinin analogue SM934
ameliorates DSS-induced mouse ulcerative colitis via suppressing
neutrophils and macrophages. Acta Pharmacol Sin. 39:1633–1644.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Newton K: RIPK1 and RIPK3: Critical
regulators of inflammation and cell death. Trends Cell Biol.
25:347–353. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Seo J, Nam YW, Kim S, Oh DB and Song J:
Necroptosis molecular mechanisms: Recent findings regarding novel
necroptosis regulators. Exp Mol Med. 53:1007–1017. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Singh V, Johnson K, Yin J, Lee S, Lin R,
Yu H, In J, Foulke-Abel J, Zachos NC, Donowitz M and Rong Y:
Chronic inflammation in ulcerative colitis causes long-term changes
in goblet cell function. Cell Mol Gastroenterol Hepatol.
13:219–232. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yao D, Dai W, Dong M, Dai C and Wu S: MUC2
and related bacterial factors: Therapeutic targets for ulcerative
colitis. EBioMedicine. 74:1037512021. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Van der Sluis M, De Koning BA, De Bruijn
AC, Velcich A, Meijerink JP, Van Goudoever JB, Büller HA, Dekker J,
Van Seuningen I, Renes IB and Einerhand AW: Muc2-deficient mice
spontaneously develop colitis, indicating that MUC2 is critical for
colonic protection. Gastroenterology. 131:117–129. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li ZY, Lin LH, Liang HJ, Li YQ, Zhao FQ,
Sun TY, Liu ZY, Zhu JY, Gu F, Xu JN, et al: Lycium barbarum
polysaccharide alleviates DSS-induced chronic ulcerative colitis by
restoring intestinal barrier function and modulating gut
microbiota. Ann Med. 55:22902132023. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wu T, Dai Y, Xue L, Sheng Y, Xu L and Xue
Y: Expression of receptor interacting protein 3 and mixed lineage
kinase domain-like protein-key proteins in necroptosis is
upregulated in ulcerative colitis. Ann Palliat Med. 8:483–489.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Feuerstein JD, Moss AC and Farraye FA:
Ulcerative colitis. Mayo Clin Proc. 94:1357–1373. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Gros B and Kaplan GG: Ulcerative colitis
in adults: A review. JAMA. 330:951–965. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Dong Y, Fan H, Zhang Z, Jiang F, Li M,
Zhou H, Guo W, Zhang Z, Kang Z, Gui Y, et al: Berberine ameliorates
DSS-induced intestinal mucosal barrier dysfunction through
microbiota-dependence and Wnt/β-catenin pathway. Int J Biol Sci.
18:1381–1397. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Fu YJ, Xu B, Huang SW, Luo X, Deng XL, Luo
S, Liu C, Wang Q, Chen JY and Zhou L: Baicalin prevents LPS-induced
activation of TLR4/NF-κB p65 pathway and inflammation in mice via
inhibiting the expression of CD14. Acta Pharmacol Sin. 42:88–96.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Rao Q, Ma G, Li M, Wu H, Zhang Y, Zhang C,
Ma Z and Huang L: Targeted delivery of triptolide by dendritic
cell-derived exosomes for colitis and rheumatoid arthritis therapy
in murine models. Br J Pharmacol. 180:330–346. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Huo Z, Li J, Li X, Xiao H, Lin Y, Ma Y, Li
J, Yang H and Zhang C: Functional fractions of Astragalus
polysaccharides as a potential prebiotic to alleviate ulcerative
colitis. Int J Biol Macromol. 271:1325802024. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Degterev A, Ofengeim D and Yuan J:
Targeting RIPK1 for the treatment of human diseases. Proc Natl Acad
Sci USA. 116:9714–9722. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Günther C, Martini E, Wittkopf N, Amann K,
Weigmann B, Neumann H, Waldner MJ, Hedrick SM, Tenzer S, Neurath MF
and Becker C: Caspase-8 regulates TNF-α-induced epithelial
necroptosis and terminal ileitis. Nature. 477:335–339. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhang J, Lei H, Hu X and Dong W:
Hesperetin ameliorates DSS-induced colitis by maintaining the
epithelial barrier via blocking RIPK3/MLKL necroptosis signaling.
Eur J Pharmacol. 873:1729922020. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhou Y and Cai Z, Zhai Y, Yu J, He Q, He
Y, Jitkaew S and Cai Z: Necroptosis inhibitors: Mechanisms of
action and therapeutic potential. Apoptosis. 29:22–44. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Newton K: Multitasking kinase RIPK1
regulates cell death and inflammation. Cold Spring Harb Perspect
Biol. 12:a0363682020. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Duan C, Xu X, Lu X, Wang L and Lu Z: RIP3
knockdown inhibits necroptosis of human intestinal epithelial cells
via TLR4/MyD88/NF-κB signaling and ameliorates murine colitis. BMC
Gastroenterol. 22:1372022. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zhao Q, Yu X, Li M, Liu Y, Han Y, Zhang X,
Li XM, Wu X, Qin J, Fang J and Zhang H: MLKL attenuates colon
inflammation and colitis-tumorigenesis via suppression of
inflammatory responses. Cancer Lett. 459:100–111. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Martini E, Krug SM, Siegmund B, Neurath MF
and Becker C: Mend your fences: The epithelial barrier and its
relationship with mucosal immunity in inflammatory bowel disease.
Cell Mol Gastroenterol Hepatol. 4:33–46. 2017. View Article : Google Scholar : PubMed/NCBI
|
